| Literature DB >> 35514753 |
Masahiro Okada1, Satoshi Shinozaki1,2, Eriko Ikeda1,3, Yoshikazu Hayashi1, Takahito Takezawa1, Hisashi Fukuda1, Takaaki Morikawa1, Masafumi Kitamura1, Munefumi Arita4, Tatsuma Nomura1, Hirotsugu Sakamoto1, Keijiro Sunada1, Noriyoshi Fukushima3, Alan Kawarai Lefor4, Hironori Yamamoto1.
Abstract
Background and Study Aims: The resection strategy for rectal neuroendocrine tumors (NET) < 10 mm is not uniform. We compared the utility of underwater endoscopic mucosal resection (UEMR) to endoscopic submucosal resection with a ligation device (ESMR-L) to resect rectal NETs. Patients andEntities:
Keywords: endoscopic submucosal resection; neuroendocrine tumor; patient outcome assessment (MeSH); rectal neoplasms; underwater endoscopic mucosal resection
Year: 2022 PMID: 35514753 PMCID: PMC9063479 DOI: 10.3389/fmed.2022.835013
Source DB: PubMed Journal: Front Med (Lausanne) ISSN: 2296-858X
FIGURE 1Endoscopic findings of a rectal neuroendocrine tumor (NET). (A) Typical rectal NET endoscopically looks like a yellow submucosal tumor covered with normal mucosa (B) magnified view shows “expanded normal pit pattern” because NETs originate from the deep mucosa and expansively grow toward the submucosa through the muscularis mucosa expanding the pits on the surface of the mucosa covering the NET. (C) When pushing a NET using the tip of a miniature probe, the NET moves with its mucosa but a submucosal tumor from the muscularis separately moves under the mucosa. (D) Endoscopic ultrasound at 20 MHz can correctly distinguish a NET from a submucosal tumor. The high-echoic submucosal layer can be identified between the NET and the muscularis. The NET was measured 5.2 mm in diameter with measuring function prepared to an endoscopic ultrasound unit.
FIGURE 2Pictures of the underwater endoscopic mucosal resection sequence. (A) Filling up the rectum with distilled water while completely aspirating residual gas. (B) Snaring the neuroendocrine tumor (NET) involving the surrounding mucosa and the submucosa under the NET. If they cannot be appropriately snared, snaring should be repeated until it is achieved. (C) When the specimen was resected, we confirm there are neither any residual tumor nor perforations under water immersion. (D) The wound was closed with endoclips during water immersion.
FIGURE 3Pictures of the endoscopic submucosal resection with a ligation device sequence. (A) Marking a neuroendocrine tumor (NET) using the tip of a loop snare with soft-coagulation mode. (B) Injecting saline into the submucosa below the NET just before following band ligation. (C) The NET ligated with a rubber band involving its surrounding mucosa and submucosa. (D) Snaring under the ligation band. (E) Cutting the ligated them with forced-coag-1 mode. (F) The wound was closed with endoclips as soon as possible after removal of the cap.
Comparison of device cost for underwater endoscopic mucosal resection without submucosal injection (UEMR) and endoscopic submucosal resection with a ligation device (ESMR-L).
| UEMR | Price | ESMR-L | Price | |
| Attachment | Disposal distal attachment | $18.20 | Pneumo-activate EVL device Black cap | $137.30 $18.20 |
| Snare | RotaSnare | $40.90 | SnareMaster | $50.00 |
| Injection | None | M-jector needle | $40.90 | |
| Clip | SureClip | $31.80 | SureClip | $31.80 |
| EZ Clip | $8.90 | EZ Clip | $8.90 |
Prices shown are in US$, US$1.00 = 110 Japanese Yen.
Comparison of characteristics and outcomes of underwater endoscopic mucosal resection without submucosal injection (UEMR) and endoscopic submucosal resection with a ligation device (ESMR-L).
| UEMR | ESMR-L | ||
| Age, years, median (IQR) | 65 (50.5–67.5) | 63 (49–68) | 0.837 |
| Gender (male/female), n | 4/3 | 17/8 | 0.667 |
| Hospitalization, n | 0 (0%) | 23 (92%) | < 0.001 |
| Previous biopsy, n | 3 (43%) | 17 (68%) | 0.379 |
| Size of lesion, mm, median (IQR) | 4 (3–5) | 4 (3–5) | 1.000 |
| Procedure time, min, median (IQR) | 6 (5–8) | 12 (9–14) | 0.002 |
| 7 (100%) | 25 (100%) | 1.000 | |
| R0 resection, n | 7 (100%) | 25 (100%) | 1.000 |
| Pathological findings, n | |||
| NET (G1) | 7 (100%) | 23 (92%) | 1.000 |
| Adverse events, n | |||
| Immediate perforation | 0 (0%) | 0 (0%) | 1.000 |
| Total cost of devices, median (IQR) | $90.45 (83.64–108.41) | $274.73 (265.86–292.45) | < 0.001 |
IQR: interquartile range, NET: neuroendocrine tumor. *Fisher’s exact test.
FIGURE 4Changing of thickness of the submucosa seen with water immersion. After fully exchanging the gas for water, the muscularis becomes circular and contracted, which makes the submucosa thickened and easy to be snared even without submucosal injection.
FIGURE 5Pathology of a resected neuroendocrine tumor (NET). (A) The specimen of a NET resected with underwater endoscopic mucosal resection, 1 cm in diameter. A NET is identified as a 3 mm yellow submucosal tumor with an obviously negative horizontal margin. The specimen was put on a piece of filter paper with its stump down to be fixed to avoid stump shrinkage. (B) Specimen with hematoxylin and eosin stain showed thick submucosa under the NET and a negative vertical margin. There was no lymph vessel invasion but there was slight venous invasion. The rossete-forming cells observed at low-magnification (hematoxylin and eosin stain, 20×).